PMC:7796041 / 10261-11336 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"242","span":{"begin":54,"end":62},"obj":"Species"},{"id":"243","span":{"begin":763,"end":771},"obj":"Species"},{"id":"244","span":{"begin":835,"end":843},"obj":"Species"},{"id":"245","span":{"begin":956,"end":964},"obj":"Species"},{"id":"246","span":{"begin":979,"end":987},"obj":"Species"},{"id":"247","span":{"begin":100,"end":112},"obj":"Disease"},{"id":"248","span":{"begin":170,"end":192},"obj":"Disease"},{"id":"249","span":{"begin":224,"end":238},"obj":"Disease"},{"id":"250","span":{"begin":256,"end":273},"obj":"Disease"},{"id":"251","span":{"begin":297,"end":304},"obj":"Disease"},{"id":"252","span":{"begin":363,"end":380},"obj":"Disease"},{"id":"253","span":{"begin":388,"end":425},"obj":"Disease"},{"id":"254","span":{"begin":427,"end":445},"obj":"Disease"},{"id":"255","span":{"begin":485,"end":499},"obj":"Disease"},{"id":"256","span":{"begin":549,"end":565},"obj":"Disease"},{"id":"257","span":{"begin":645,"end":666},"obj":"Disease"},{"id":"258","span":{"begin":1010,"end":1017},"obj":"Disease"},{"id":"259","span":{"begin":1038,"end":1046},"obj":"Disease"}],"attributes":[{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"Tax:9606"},{"id":"A243","pred":"tao:has_database_id","subj":"243","obj":"Tax:9606"},{"id":"A244","pred":"tao:has_database_id","subj":"244","obj":"Tax:9606"},{"id":"A245","pred":"tao:has_database_id","subj":"245","obj":"Tax:9606"},{"id":"A246","pred":"tao:has_database_id","subj":"246","obj":"Tax:9606"},{"id":"A247","pred":"tao:has_database_id","subj":"247","obj":"MESH:D006973"},{"id":"A248","pred":"tao:has_database_id","subj":"248","obj":"MESH:D002318"},{"id":"A249","pred":"tao:has_database_id","subj":"249","obj":"MESH:D009202"},{"id":"A250","pred":"tao:has_database_id","subj":"250","obj":"MESH:D003920"},{"id":"A251","pred":"tao:has_database_id","subj":"251","obj":"MESH:D009765"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"MESH:D008171"},{"id":"A253","pred":"tao:has_database_id","subj":"253","obj":"MESH:D029424"},{"id":"A254","pred":"tao:has_database_id","subj":"254","obj":"MESH:D011658"},{"id":"A255","pred":"tao:has_database_id","subj":"255","obj":"MESH:D009369"},{"id":"A256","pred":"tao:has_database_id","subj":"256","obj":"MESH:D007153"},{"id":"A257","pred":"tao:has_database_id","subj":"257","obj":"MESH:D006402"},{"id":"A258","pred":"tao:has_database_id","subj":"258","obj":"MESH:D013575"},{"id":"A259","pred":"tao:has_database_id","subj":"259","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Median age was 64.1 ± 16.7 years, and the majority of patients were male (n = 108, 65.1%). Arterial hypertension constituted the most common risk factor (n = 83, 50.0%). Cardiovascular disease was present in 18.1% (n = 30), cardiomyopathy in 3.0% (n = 5), diabetes mellitus in 17.5% (n = 29), and obesity in 21.7% (n = 36). Other relevant comorbidities comprised pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary fibrosis) in 14.5% (n = 24), previous or active cancer disease in 8.4% (n = 14), and conditions associated with immunodeficiency (e.g., due to chronic immunosuppression therapy after organ transplantation or hematological disease) in 8.4% (n = 14). Information on left ventricular ejection fraction (LVEF) was available in 44 patients (26.5%). Mean LVEF in this subgroup was 53.0 ± 12.3%. In three patients a cardiac pacemaker had been implanted (1.8%). Implanted cardioverter-defibrillators (ICDs) were present in two patients (1.2%). Seven patients (4.2%) presented with syncope in association with COVID-19 prior to hospital admission."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T49","span":{"begin":100,"end":112},"obj":"Phenotype"},{"id":"T50","span":{"begin":170,"end":192},"obj":"Phenotype"},{"id":"T51","span":{"begin":224,"end":238},"obj":"Phenotype"},{"id":"T52","span":{"begin":256,"end":273},"obj":"Phenotype"},{"id":"T53","span":{"begin":297,"end":304},"obj":"Phenotype"},{"id":"T54","span":{"begin":388,"end":425},"obj":"Phenotype"},{"id":"T55","span":{"begin":427,"end":445},"obj":"Phenotype"},{"id":"T56","span":{"begin":485,"end":491},"obj":"Phenotype"},{"id":"T57","span":{"begin":549,"end":565},"obj":"Phenotype"},{"id":"T58","span":{"begin":645,"end":666},"obj":"Phenotype"},{"id":"T59","span":{"begin":1010,"end":1017},"obj":"Phenotype"}],"attributes":[{"id":"A49","pred":"hp_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/HP_0000822"},{"id":"A50","pred":"hp_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/HP_0001626"},{"id":"A51","pred":"hp_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/HP_0001638"},{"id":"A52","pred":"hp_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/HP_0000819"},{"id":"A53","pred":"hp_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/HP_0001513"},{"id":"A54","pred":"hp_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/HP_0006510"},{"id":"A55","pred":"hp_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/HP_0002206"},{"id":"A56","pred":"hp_id","subj":"T56","obj":"http://purl.obolibrary.org/obo/HP_0002664"},{"id":"A57","pred":"hp_id","subj":"T57","obj":"http://purl.obolibrary.org/obo/HP_0002721"},{"id":"A58","pred":"hp_id","subj":"T58","obj":"http://purl.obolibrary.org/obo/HP_0001871"},{"id":"A59","pred":"hp_id","subj":"T59","obj":"http://purl.obolibrary.org/obo/HP_0001279"}],"text":"Median age was 64.1 ± 16.7 years, and the majority of patients were male (n = 108, 65.1%). Arterial hypertension constituted the most common risk factor (n = 83, 50.0%). Cardiovascular disease was present in 18.1% (n = 30), cardiomyopathy in 3.0% (n = 5), diabetes mellitus in 17.5% (n = 29), and obesity in 21.7% (n = 36). Other relevant comorbidities comprised pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary fibrosis) in 14.5% (n = 24), previous or active cancer disease in 8.4% (n = 14), and conditions associated with immunodeficiency (e.g., due to chronic immunosuppression therapy after organ transplantation or hematological disease) in 8.4% (n = 14). Information on left ventricular ejection fraction (LVEF) was available in 44 patients (26.5%). Mean LVEF in this subgroup was 53.0 ± 12.3%. In three patients a cardiac pacemaker had been implanted (1.8%). Implanted cardioverter-defibrillators (ICDs) were present in two patients (1.2%). Seven patients (4.2%) presented with syncope in association with COVID-19 prior to hospital admission."}

{"project":"LitCovid-sentences","denotations":[{"id":"T91","span":{"begin":0,"end":90},"obj":"Sentence"},{"id":"T92","span":{"begin":91,"end":169},"obj":"Sentence"},{"id":"T93","span":{"begin":170,"end":323},"obj":"Sentence"},{"id":"T94","span":{"begin":324,"end":685},"obj":"Sentence"},{"id":"T95","span":{"begin":686,"end":780},"obj":"Sentence"},{"id":"T96","span":{"begin":781,"end":825},"obj":"Sentence"},{"id":"T97","span":{"begin":826,"end":890},"obj":"Sentence"},{"id":"T98","span":{"begin":891,"end":972},"obj":"Sentence"},{"id":"T99","span":{"begin":973,"end":1075},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Median age was 64.1 ± 16.7 years, and the majority of patients were male (n = 108, 65.1%). Arterial hypertension constituted the most common risk factor (n = 83, 50.0%). Cardiovascular disease was present in 18.1% (n = 30), cardiomyopathy in 3.0% (n = 5), diabetes mellitus in 17.5% (n = 29), and obesity in 21.7% (n = 36). Other relevant comorbidities comprised pulmonary disease (e.g., chronic obstructive pulmonary disease, pulmonary fibrosis) in 14.5% (n = 24), previous or active cancer disease in 8.4% (n = 14), and conditions associated with immunodeficiency (e.g., due to chronic immunosuppression therapy after organ transplantation or hematological disease) in 8.4% (n = 14). Information on left ventricular ejection fraction (LVEF) was available in 44 patients (26.5%). Mean LVEF in this subgroup was 53.0 ± 12.3%. In three patients a cardiac pacemaker had been implanted (1.8%). Implanted cardioverter-defibrillators (ICDs) were present in two patients (1.2%). Seven patients (4.2%) presented with syncope in association with COVID-19 prior to hospital admission."}